These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 32375405)

  • 1. PPAR Beta/Delta and the Hallmarks of Cancer.
    Wagner N; Wagner KD
    Cells; 2020 May; 9(5):. PubMed ID: 32375405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.
    Wagner N; Wagner KD
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD; Wagner N
    Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.
    Monsalve FA; Pyarasani RD; Delgado-Lopez F; Moore-Carrasco R
    Mediators Inflamm; 2013; 2013():549627. PubMed ID: 23781121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand Binding.
    Schwarz R; Tänzler D; Ihling CH; Sinz A
    PLoS One; 2016; 11(3):e0151412. PubMed ID: 26992147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
    Bishop-Bailey D; Bystrom J
    Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma.
    Leone P; Solimando AG; Prete M; Malerba E; Susca N; Derakhshani A; Ditonno P; Terragna C; Cavo M; Silvestris N; Racanelli V
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
    Bedu E; Wahli W; Desvergne B
    Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of PPARβ/δ in the management of metabolic syndrome and its associated cardiovascular complications.
    Benetti E; Patel NS; Collino M
    Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):273-84. PubMed ID: 21696362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.
    Yao PL; Morales JL; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Mol Cancer Ther; 2014 Apr; 13(4):1008-17. PubMed ID: 24464939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.
    Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C
    J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity.
    Zuo X; Wu Y; Morris JS; Stimmel JB; Leesnitzer LM; Fischer SM; Lippman SM; Shureiqi I
    Oncogene; 2006 Feb; 25(8):1225-41. PubMed ID: 16288226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Regulation of PPARs through Post-Translational Modifications.
    Brunmeir R; Xu F
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
    Qi C; Zhu Y; Reddy JK
    Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.
    Coll T; Rodrïguez-Calvo R; Barroso E; Serrano L; Eyre E; Palomer X; Vázquez-Carrera M
    Curr Mol Pharmacol; 2009 Jan; 2(1):46-55. PubMed ID: 20021445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy.
    Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB
    Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer.
    Psilopatis I; Vrettou K; Troungos C; Theocharis S
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional strategies to modulate inflammation pathways via regulation of peroxisome proliferator-activated receptor β/δ.
    da Cruz BO; Cardozo LFMF; Magliano DC; Stockler-Pinto MB
    Nutr Rev; 2020 Mar; 78(3):207-214. PubMed ID: 31584650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.